Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT03738267
Eligibility Criteria:
Inclusion Criteria:
* 18 year old woman or over at the time of participation
* PS 0 -2
* Cancer diagnosed (biopsy date) from 01/01/2010 between the second week of pregnancy and the 12 months postpartum.
* Primitive may concern the following sites:
oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, prevalent lymphadenopathy, nasal cavity, salivary glands, dental tumors, ear tumors, paragangliomas optic pathways, facial sinus / facial mass, nose, ear and other head and neck
* All histologies (epithelial tumors, sarcomas, mucosal melanomas, embryonic tumors, undifferentiated tumors)
* Patient receiving or having received a specific oncological treatment among surgery, radiotherapy, chemotherapy, hormone therapy.
* All stages allowed: localized stages and metastatic stages immediately.
* No opposition of the patient to participate in this study
Exclusion Criteria:
* Any other neoplastic antecedent
* Exclusion of metastases at the level of the VADS of another primitive than a cancer of the VADS
* Exclusion of hematological tumors (lymphoma) and glial tumors
* Person subject to a legal protection measure or unable to express their consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03738267
Study Brief:
Protocol Section:
NCT03738267